| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |